Jeff Geschwind, MD & HistoSonics Jeff Geschwind, MD, serves as Medical Advisor for HistoSonics, a company revolutionizing non-invasive liver cancer therapy. His contributions help advance tumor ablation technologies, offering hope to patients with inoperable cancers. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/